Zhejiang Starry Pharmaceutical Co., Ltd. Class ASSE: 603520

Announcement on "Corporate Value and Return Enhancement" Action Plan

· Issued by Zhejiang Starry Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on "Corporate Value and Return Enhancement" Action Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment